Antenatal corticosteroids and outcomes of small for gestational age infants born at 24-31 gestational weeks: a population-based propensity score matching analysis
- PMID: 36352162
- DOI: 10.1007/s00404-022-06834-4
Antenatal corticosteroids and outcomes of small for gestational age infants born at 24-31 gestational weeks: a population-based propensity score matching analysis
Abstract
Purpose: To evaluate the effect of antenatal corticosteroid (ACS) treatment on neonatal outcomes in small for gestational age (SGA) infants born at 24-31 gestational weeks compared with non-SGA infants.
Methods: A population-based retrospective study was conducted that analyzed clinical data from the Neonatal Research Network of Japan database, which enrolls neonates born at < 32 gestational weeks and weighing 1500 g or less (n = 22,414). Propensity score matching (with the ratio of ACS to no-ACS groups of 1:1) was performed in SGA (n = 7028) and non-SGA (n = 15,386) infants, respectively. Univariate logistic and interaction analyses were performed to compare the short-term neonatal outcomes of infants with and without ACS treatment in utero.
Results: In the SGA and non-SGA infants, ACS treatment significantly reduced in-hospital mortality (odds ratio 0.67 95% confidence interval [0.50-0.88] and 0.62 [0.50-0.78], respectively), respiratory distress syndrome (0.77 [0.69-0.87] and 0.63 [0.58-0.68], respectively), and composite adverse outcomes (0.73 [0.58-0.91] and 0.57 [0.50-0.65], respectively). ACS treatment also significantly reduced intraventricular hemorrhage (grade III/IV), periventricular leukomalacia, and sepsis in the non-SGA infants, but not in the SGA infants. However, interaction analyses revealed no significant differences between the SGA and non-SGA infants in the efficacy of ACS treatment on short-term outcomes except for respiratory distress syndrome.
Conclusions: ACS treatment was associated with beneficial effects on mortality, respiratory distress syndrome, and adverse composite outcomes in extremely and very preterm SGA infants, with similar efficacy on all neonatal outcomes except for respiratory distress syndrome observed in the non-SGA infants.
Keywords: Antenatal corticosteroids; Neonatal morbidity; Neonatal mortality; Preterm infants; Small for gestational age.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Dose completion of antenatal corticosteroids and neonatal outcomes in non-small-for-gestational age or small-for-gestational age very-low-birthweight infants: A Korean population-based cohort study.Pediatr Neonatol. 2022 Mar;63(2):165-171. doi: 10.1016/j.pedneo.2021.08.020. Epub 2021 Nov 20. Pediatr Neonatol. 2022. PMID: 34887230
-
[Effect of antenatal corticosteroids therapy on the mortality and morbidity of small for gestational age infants born at 24-34 completed weeks: a retrospective multicenter study].Zhonghua Er Ke Za Zhi. 2017 Aug 2;55(8):613-618. doi: 10.3760/cma.j.issn.0578-1310.2017.08.013. Zhonghua Er Ke Za Zhi. 2017. PMID: 28822438 Chinese.
-
Antenatal corticosteroid treatment in singleton, small-for-gestational-age infants born at 24-31 weeks' gestation: a population-based study.BJOG. 2016 Oct;123(11):1779-86. doi: 10.1111/1471-0528.13723. Epub 2015 Nov 10. BJOG. 2016. PMID: 26552861
-
Antenatal corticosteroids in preterm small-for-gestational age infants: a systematic review and meta-analysis.Am J Obstet Gynecol MFM. 2020 Nov;2(4):100215. doi: 10.1016/j.ajogmf.2020.100215. Epub 2020 Aug 17. Am J Obstet Gynecol MFM. 2020. PMID: 33345924 Free PMC article.
-
Corticosteroids for preventing neonatal respiratory morbidity after elective caesarean section at term.Cochrane Database Syst Rev. 2018 Aug 3;8(8):CD006614. doi: 10.1002/14651858.CD006614.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2021 Dec 22;12:CD006614. doi: 10.1002/14651858.CD006614.pub4. PMID: 30075059 Free PMC article. Updated.
References
-
- Vollmer B, Edmonds CJ (2019) School age neurological and cognitive outcomes of fetal growth retardation or small for gestational age birth weight. Front Endocrinol 10:186 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical